Incidence of hepatocellular carcinoma in patients with hepatitis C treated with direct-acting antivirals agents: results of a long-term prospective study period

被引：0
|
作者：
De Santis, Emanuela [1 ]
Caioli, Alessandro [1 ]
De Angelis, Fernando [1 ]
De Santis, Adriano [1 ]
机构：
[1] Sapienza Univ Rome, Rome, Italy
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-414
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [21] Advances in the Era of Direct-Acting Antivirals for Hepatitis C in Patients with Unresectable Hepatocellular Carcinoma
    Chen, Li-Shu
    Lee, Shou-Wu
    Yang, Sheng-Shun
    Tsai, Hsin-Ju
    Lee, Teng-Yu
    DIGESTIVE DISEASES, 2022, 40 (05) : 616 - 624
  • [22] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [23] Occurrence of hepatocellular carcinoma in patients with hepatitis C virus related liver disease treated with direct-acting antivirals
    Calvaruso, V.
    Cabibbo, G.
    Cacciola, I.
    Petta, S.
    Madonia, S.
    Bellia, A.
    Stefano, M. D.
    Giannitrapani, L.
    Tine, F.
    Magro, A.
    Davi, A.
    Larocca, L.
    Ardiri, A.
    Digiacomo, A.
    Gussio, M.
    Guarneri, L.
    Scalisi, I.
    Mazzola, G.
    Cartabellotta, F.
    Savalli, F.
    Russello, M.
    Scifo, G.
    Squadrito, G.
    Camma, C.
    Raimondo, G.
    Craxi, A.
    Di Marco, V.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S23 - S24
  • [24] Effect of direct-acting antivirals on hepatocellular carcinoma incidence in hepatitis C virus-related cirrhosis
    Navani, V.
    Chan, P.
    Borchard, J.
    Ladera, A.
    Coppock, J.
    Turner, I.
    Shackel, N.
    Levy, M.
    Davison, S.
    Prakoso, E.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 75 - 75
  • [25] No difference between direct-acting antivirals for hepatitis C in hepatocellular carcinoma risk
    Mun, Elijah J.
    Green, Pamela
    Berry, Kristin
    Ioannou, George N.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2019, 31 (01) : 47 - 52
  • [26] Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C
    Tagkou, Nikoletta M.
    Goossens, Nicolas
    Negro, Francesco
    HEPATOMA RESEARCH, 2022, 8
  • [27] No Difference between Direct-Acting Antivirals for Hepatitis C in Hepatocellular Carcinoma Risk
    Mun, Elijah
    Green, Pamela
    Berry, Kristin
    Ioannou, George
    HEPATOLOGY, 2018, 68 : 389A - 389A
  • [28] REGRESSION OF HEPATIC FIBROSIS IN PATIENTS WITH CHRONIC HEPATITIS C TREATED WITH DIRECT-ACTING ANTIVIRALS (DAAS). A LONG-TERM OBSERVATIONAL STUDY.
    Triantos, Christos
    Kanaloupitis, Stavros
    Zisimopoulos, Konstantinos A.
    Aggeletopoulou, Ioanna
    Kalafateli, Maria
    Diamantopoulou, Georgia
    Tsintoni, Aggeliki
    Thomopoulos, Konstantinos
    GASTROENTEROLOGY, 2020, 158 (06) : S1323 - S1323
  • [29] Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
    Fiehn, Felix
    Beisel, Claudia
    Binder, Marco
    CURRENT OPINION IN VIROLOGY, 2024, 67
  • [30] Hepatitis B Reactivation in Patients Treated with Direct-Acting Antivirals for Hepatitis C
    Toka, Bilal
    Koksal, Aydin Seref
    Dertli, Ramazan
    Sirin, Goktug
    Fidan, Sami
    Ulger, Yakup
    Harmandar, Ferda
    Yildirim, Abdullah Emre
    Eminler, Ahmet Tarik
    Asil, Mehmet
    Kayar, Yusuf
    Biyik, Murat
    Kuran, Sedef
    Uslan, Mustafa Ihsan
    Hulagu, Sadettin
    DIGESTIVE DISEASES, 2022, : 635 - 643
12345